Browse Category

Mergers & Acquisitions 8 November 2025 - 12 November 2025

Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Baytex Energy (BTE.TO) Sells Eagle Ford Assets for US$2.305 Billion; Stock Jumps After CIRO Halt — Nov. 12, 2025

Baytex Energy Corp. said today it has signed a definitive agreement to sell all of its U.S. Eagle Ford assets to an **undisclosed buyer for US$2.305 billion in cash. Management framed the deal as a pivot to “a focused, high‑return Canadian energy producer,” emphasizing heavy oil, Viking light oil, and the rapidly scaling Pembina Duvernay. baytexenergy.com
12 November 2025
·····
Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics (CWAN) Weighs Sale; Shares Jump as Wellington Files 6.2% Stake and New Report Flags $2.7T Insurance ‘Alts’ Shift

Clearwater Analytics Holdings, Inc. is in the spotlight today after Bloomberg reported the investment‑software company is considering a potential sale following inbound takeover interest. The headline sent CWAN shares higher in Wednesday trading, coinciding with a new industry study the company released on insurers’ growing allocations to alternative assets and a fresh Schedule 13G filing showing Wellington Management as a ≥5% shareholder. SEC+3Bloomberg Law+3
12 November 2025
··
CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

CMCT Sells Lending Arm to Peachtree Affiliate for ~$44M; Stock Jumps, CFO Transition Set — Nov. 12, 2025

Creative Media & Community Trust Corporation said it has signed a definitive agreement to sell its lending division to PG FR Holding, LLC, an affiliate of Atlanta-based Peachtree Group. The deal is expected to generate approximately $31 million in net cash for CMCT at closing and advances the company’s pivot toward multifamily growth and balance-sheet strength. Business Wire+1
12 November 2025
···
Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals (SLRX) Stock Jumps as $7M Offering Prices; Closing Expected November 12, 2025 Amid Decoy Therapeutics Merger

Salarius Pharmaceuticals, Inc. is back in the headlines today after pricing a $7 million underwritten public offering tied to its pending business combination with Decoy Therapeutics. The company said the deal is expected to close “on or about November 12, 2025,” pending customary conditions, including consummation of the Decoy transaction. PR Newswire
12 November 2025
···
Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance (NASDAQ: PSKY) Jumps on First Post‑Merger Earnings: $1.5B Content Push, $3B Cost Cuts, Paramount+ Price Hike — 11/11/2025

Paramount Skydance Corporation reported its first results since the Skydance–Paramount merger and the stock rallied after management laid out a bigger streaming-and-studios investment plan and raised its cost‑savings target. Shares were up ~5.5% today as CEO David Ellison emphasized a tech‑forward overhaul, a fatter content slate, and a sharper path to profitability. Reuters
11 November 2025
··
C3.ai (AI) shares edge higher as company explores sale — everything new on November 11, 2025

C3.ai (AI) shares edge higher as company explores sale — everything new on November 11, 2025

C3.ai, Inc. is in the spotlight today after a late‑Monday Reuters exclusive said the enterprise‑AI software maker is exploring a potential sale as part of a broader strategic review following its recent leadership transition. Additional outlets echoed the report overnight in Asia and Europe, and traders are watching for follow‑on headlines ahead of the company’s next earnings date in early December. reuters.com+2thestar.com.my+2
11 November 2025
····
Shiseido cuts 2025 outlook to ¥52bn net loss, books ¥46.8bn Americas impairment and launches 200‑person voluntary exit

Shiseido cuts 2025 outlook to ¥52bn net loss, books ¥46.8bn Americas impairment and launches 200‑person voluntary exit

Japan’s Shiseido Co. slashed its full‑year guidance and flagged deeper restructuring, warning it now expects a ¥52 billion net loss for the year to December 31, 2025, versus a previous forecast for a ¥6 billion profit. The cosmetics group cited a goodwill impairment in the Americas and softer demand as it also unveiled a new medium‑term strategy through 2030. Shiseido Corporation+1
10 November 2025
·
Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Metsera (MTSR) Sinks as Pfizer Seals Revised $10B Buyout; 8‑K Spells Out $65.60 Cash + Up to $20.65 CVR — Nov. 10, 2025

Shares of Metsera, Inc. slumped on Monday after the obesity‑drug developer said it will proceed with a sweetened takeover by Pfizer that ends a high‑stakes bidding war with Novo Nordisk. Metsera accepted Pfizer’s revised offer late Friday; Novo dropped out over the weekend. In early U.S. trading today, MTSR fell ~15% as investors recalibrated expectations around the final deal structure.
10 November 2025
····
Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano (NASDAQ: MOVE) Soars on All‑Stock Merger With Corvex to Create Secure AI‑Infrastructure Pure Play — Nov. 10, 2025

Movano Inc. and Corvex, Inc., a GPU‑accelerated AI cloud company, signed a definitive all‑stock merger agreement. The combined business will focus squarely on secure, high‑performance AI infrastructure—including GPU clusters for training/inference, confidential computing, and inference‑as‑a‑service—repositioning Movano away from consumer health wearables. Upon closing, “Movano Inc.” will be renamed “Corvex, Inc.” and move its headquarters to Arlington, Virginia. PR Newswire
10 November 2025
···
Ondas Holdings (ONDS) names ex‑Rafael chief Yoav Har‑Even to OAS advisory board as Sentrycs acquisition advances — Nov. 10, 2025

Ondas Holdings (ONDS) names ex‑Rafael chief Yoav Har‑Even to OAS advisory board as Sentrycs acquisition advances — Nov. 10, 2025

Ondas Holdings Inc. announced that Maj. Gen. Yoav Har‑Even, former President & CEO of Rafael Advanced Defense Systems, has joined the advisory board of Ondas Autonomous Systems, the company’s defense and security robotics unit. The move adds a veteran of multi‑domain operations and large defense programs to OAS at a time when Ondas is expanding its counter‑UAS and autonomous platforms portfolio. Ondas Holdings Inc.
10 November 2025
·
Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Novo Nordisk and Pfizer Stocks Today (Nov. 10, 2025): Pfizer Clinches $10B Metsera Deal as Novo Rises on Exit and India Brand Move

Summary: On Monday, Pfizer said it will acquire obesity‑drug developer Metsera in a deal worth up to $10 billion, while Novo Nordisk shares climbed after bowing out of the bidding war. Governance drama around Novo’s board intensified as Norway’s $1.5 trillion sovereign wealth fund said it would abstain from key votes this week. Separately, Novo struck a distribution pact in India to sell a new branded version of its semaglutide weight‑loss shot. Reuters+3Reuters+3Reuters+3
10 November 2025
··
Pandox Completes €1.7bn Dalata Takeover: Dalata Delists Today as Scandic Takes Over 56 Hotels (10 Nov 2025)

Pandox Completes €1.7bn Dalata Takeover: Dalata Delists Today as Scandic Takes Over 56 Hotels (10 Nov 2025)

Summary: Dalata Hotel Group plc has been formally delisted this morning following the completion of its acquisition by a Pandox AB–Eiendomsspar AS consortium. Scandic Hotels Group has begun managing Dalata’s 56 hotels under an interim management agreement and intends to acquire the operating platform for €500 million after a carve‑out, while Pandox will retain 31 investment properties in Ireland and the UK under long‑term, revenue‑based leases once the separation is complete. pandox.se+3pandox.se+3Investegate+3
10 November 2025
··
Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb (BMY) today: €5B euro‑notes closing, $239M Celgene suit settlement, BioNTech cash flows lift guidance — what to watch on November 9, 2025

Bristol‑Myers Squibb priced €5 billion in senior unsecured notes across five tranches — €750M 2030, €1.15B 2033, €1.15B 2038, €750M 2045, and €1.2B 2055 — with closing anticipated Nov. 10, 2025. The notes are guaranteed by Bristol‑Myers Squibb Company. Bristol Myers Squibb News
9 November 2025
··
1 … 13 14 15 16 17 … 20
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 BUY ON PULLBACK

Microsoft

NASDAQ: MSFT 94 / 100
#2 BUY

L3Harris Technologies

NYSE: LHX 90 / 100
#3 BUY

Xylem

NYSE: XYL 89 / 100
#4 BUY IN TRANCHES

Lam Research

NASDAQ: LRCX 87 / 100
#5 BUY ON WEAKNESS

GE HealthCare

NASDAQ: GEHC 84 / 100
View full portfolio
Editorial model selection. Not personalised advice.